1. 1504TiPNintedanib plus docetaxel in routine clinical practice: VARGADO, a German prospective non-interventional study (NIS) reflecting routine treatment conditions in an evolving NSCLC treatment landscape. (23rd October 2018) Authors: Grohe, C; Zander, I; Lüdtke-Heckenkamp, K; Blau, W; Krüger, S; Franke, C; Mueller-Huesmann, H; Brückl, W M; Basara, N; Ukena, D; Lang, S; Atz, J; Kaiser, R Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 739PQuality of life (QoL) in patients with metastatic pancreatic cancer receiving first-line Nab-paclitaxel/gemcitabine chemotherapy: Results of the large QoL study AIO-QoliXane/PARAGON. (23rd October 2018) Authors: Schönherr, C; Götze, T O; zur Hausen, G; Reichart, A; Pauligk, C; Schlag, R; Siegler, G M; Dörfel, S; Aldaoud, A; Hahn, L; Schubert, J; Zahn, M-O; Höffkes, H-G; Reiser, M; Koenigsmann, M; Blau, W; Waidmann, O; Homann, N; Trojan, J; Al-Batran, S-E Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗